Niki BioSolutions, Inc. (NIKI) Operating Leases (2020 - 2025)

Niki BioSolutions' (NIKI) quarterly Operating Leases came in at $3324.0 in Q4 2025, down 91.28% on a QoQ basis from $38126.0 in Q3 2025.

Niki BioSolutions, Inc. (NIKI) Operating Leases (2020 - 2025) Analysis & Trends

Niki BioSolutions (NIKI) has 6 years of Operating Leases data on file, last reported at $3324.0 in Q4 2025.

Quarterly Operating Leases changed N/A year-over-year to $3324.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $3324.0 (changed N/A YoY) and the FY2025 annual result came in at $24428.0, up 72.25% from the prior year.
Operating Leases declined to $3324.0 in Q4 2025, from $38126.0 in the prior quarter.
In the past five years, Operating Leases ranged from a high of $199076.0 in Q2 2023 to a low of $3324.0 in Q4 2025.
A 5-year average of $66629.6 and a median of $34455.0 in 2022 frame the typical range for Operating Leases.
Annual changes were most pronounced in 2021 — Operating Leases sank 84.62% — and 2023, when it surged 223.17%.
Tracing NIKI's Operating Leases over 5 years: stood at $23853.0 in 2021, then increased by 29.06% to $30784.0 in 2022, then surged by 223.17% to $99485.0 in 2023, then slumped by 77.85% to $22036.0 in 2024, then tumbled by 84.92% to $3324.0 in 2025.
The last three Operating Leases figures came in at $3324.0 (Q4 2025), $38126.0 (Q3 2025), and $22698.0 (Q2 2025), per Business Quant data.

Download Data